Skip to main content

Table 3 Binax-CoV2 performance characteristics in the emergency department setting

From: Should rapid antigen tests be first-line for COVID-19 testing? Results of a prospective urban cohort study

 

Emergency Department Setting

      

Binax-CoV2 Result

RT-PCR (+) Patients

RT-PCR (-) Patients

Prevalence

Sensitivity

Specificity

PPV

NPV

Total

All patients

Positive

9

1

0.19

0.53

0.99

0.90

0.90

10

Negative

8

70

78

Total

 

17

71

     

88

Symptomatic patients

Positive

3

0

0.33

0.60

1.00

1.00

0.83

3

Negative

2

10

12

Total

 

5

10

     

15

Asymptomatic patients

Positive

6

0

0.22

0.38

1.00

1.00

0.85

6

Negative

10

57

67

Total

 

16

57

     

73

ED Event 1

Positive

6

1

0.29

0.43

0.97

0.86

0.80

7

Negative

8

33

41

Total

 

14

34

     

48

ED Event 1a

Positive

5

1

0.18

0.71

0.97

0.83

0.94

6

Negative

2

31

33

Total

 

7

32

     

39

  1. Abbreviations: Binax-CoV2 Abbott BinaxNOW™ COVID-19 Ag Card, RT-qPCR reverse transcription quantitative polymerase chain reaction, CI confidence interval, PPV positive predictive value, NPV Negative predictive value
  2. aExcluding patients that had a prior positive COVID-19 test in the previous 2 weeks